Currently approved viral vector-based and mRNA-based vaccine approaches against
coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After …

Atopic asthma is a chronic inflammatory pulmonary disease characterised by recurrent
episodes of wheezy, laboured breathing with an underlying Th2 cell-mediated inflammatory …

Background Elucidating the role of T cell responses in COVID-19 is of utmost importance to
understand the clearance of SARS-CoV-2 infection. Methods 30 hospitalized COVID-19 …

Neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike
(S) block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into cells …

Immune responses are tightly regulated to ensure efficient pathogen clearance while avoiding
tissue damage. Here we report that Setdb2 was the only protein lysine methyltransferase …

Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as
the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with …

Macrolide antibiotics possess immunomodulatory/anti-inflammatory properties. These
properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of …

Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19,
ChAd) followed by an mRNA vaccine (eg BNT162b2, BNT) has been reported to be superior …

Antigen-specific tissue-resident memory T cells (Trms) and neutralizing IgA antibodies provide
the most effective protection of the lungs from viral infections. To induce those essential …

Since the beginning of the COVID-19 pandemic, divergent variants of concern (VoCs) of
SARS-CoV-2 have evolved and become the most prevalent SARS-CoV-2 variants in distinct …